Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Change in Account Payables (2023 - 2025)

Historic Change in Account Payables for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$775167.0.

  • Onconetix's Change in Account Payables fell 18189.32% to -$775167.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year decrease of 28005.89%. This contributed to the annual value of -$1.5 million for FY2024, which is 14379.57% down from last year.
  • Per Onconetix's latest filing, its Change in Account Payables stood at -$775167.0 for Q3 2025, which was down 18189.32% from -$11439.0 recorded in Q2 2025.
  • Onconetix's 5-year Change in Account Payables high stood at $2.0 million for Q4 2023, and its period low was -$1.2 million during Q1 2023.
  • Over the past 3 years, Onconetix's median Change in Account Payables value was -$235004.0 (recorded in 2024), while the average stood at $77055.0.
  • Within the past 5 years, the most significant YoY rise in Onconetix's Change in Account Payables was 9902.33% (2025), while the steepest drop was 18189.32% (2025).
  • Onconetix's Change in Account Payables (Quarter) stood at $2.0 million in 2023, then crashed by 112.02% to -$235004.0 in 2024, then crashed by 229.85% to -$775167.0 in 2025.
  • Its last three reported values are -$775167.0 in Q3 2025, -$11439.0 for Q2 2025, and -$261362.0 during Q1 2025.